Monoclonal_JJ
anti-endothelial_JJ
cell_NN
antibodies_NNS
from_IN
a_DT
patient_NN
with_IN
Takayasu_NN
arteritis_NN
activate_VBP
endothelial_JJ
cells_NNS
from_IN
large_JJ
vessels_NNS
._.

OBJECTIVE_NN
:_:
To_TO
create_VB
monoclonal_JJ
anti-endothelial_JJ
cell_NN
antibodies_NNS
-LRB-_-LRB-
mAECA_NNS
-RRB-_-RRB-
from_IN
a_DT
patient_NN
with_IN
Takayasu_NN
arteritis_NN
to_TO
evaluate_VB
their_PRP$
ability_NN
to_TO
activate_VB
human_JJ
umbilical_JJ
vein_NN
endothelial_JJ
cells_NNS
-LRB-_-LRB-
HUVEC_NN
-RRB-_-RRB-
,_,
and_CC
to_TO
characterize_VB
the_DT
mechanism_NN
of_IN
EC_NN
activation_NN
._.

METHODS_NNS
:_:
A_DT
panel_NN
of_IN
mAECA_NNS
was_VBD
generated_VBN
from_IN
peripheral_JJ
blood_NN
lymphocytes_NNS
of_IN
a_DT
patient_NN
with_IN
Takayasu_NN
arteritis_NN
,_,
using_VBG
Epstein-Barr_JJ
virus_NN
transformation_NN
._.

Activity_NN
against_IN
macrovascular_JJ
EC_NN
-LRB-_-LRB-
HUVEC_NN
-RRB-_-RRB-
and_CC
microvascular_JJ
EC_NN
-LRB-_-LRB-
human_JJ
bone_NN
marrow_NN
EC_NN
immortalized_VBN
by_IN
SV40_NN
-RRB-_-RRB-
antigens_NNS
was_VBD
detected_VBN
by_IN
enzyme-linked_JJ
immunosorbent_JJ
assay_NN
._.

Inhibition_NN
studies_NNS
were_VBD
used_VBN
to_TO
select_VB
the_DT
monoclonal_JJ
antibodies_NNS
-LRB-_-LRB-
mAECA_NNS
-RRB-_-RRB-
which_WDT
share_VBP
the_DT
same_JJ
EC_NN
epitope_NN
binding_NN
specificity_NN
as_IN
the_DT
total_JJ
IgG-AECA_NN
from_IN
the_DT
Takayasu_NN
arteritis_NN
patient_NN
._.

The_DT
binding_NN
of_IN
the_DT
mAECA_NNS
to_TO
human_JJ
aortic_JJ
EC_NNS
was_VBD
studied_VBN
by_IN
immunohistochemistry_NN
._.

The_DT
secretion_NN
levels_NNS
of_IN
interleukin-6_NN
-LRB-_-LRB-
IL-6_NN
-RRB-_-RRB-
and_CC
von_NN
Willebrand_NN
factor_NN
-LRB-_-LRB-
vWF_NN
-RRB-_-RRB-
were_VBD
determined_VBN
,_,
to_TO
serve_VB
as_IN
markers_NNS
for_IN
EC_NN
activation_NN
._.

The_DT
activated_VBN
EC_NN
were_VBD
examined_VBN
for_IN
the_DT
adherence_NN
of_IN
a_DT
monocytic_JJ
cell_NN
line_NN
-LRB-_-LRB-
U937_NN
-RRB-_-RRB-
,_,
as_RB
well_RB
as_IN
for_IN
expression_NN
of_IN
vascular_JJ
cell_NN
adhesion_NN
molecule_NN
1_CD
,_,
intercellular_JJ
adhesion_NN
molecule_NN
1_CD
,_,
and_CC
E-selectin_NN
._.

In_IN
addition_NN
,_,
nuclear_JJ
extracts_NNS
of_IN
the_DT
mAECA-treated_JJ
EC_NN
were_VBD
analyzed_VBN
for_IN
the_DT
induction_NN
of_IN
translocation_NN
of_IN
nuclear_JJ
factor_NN
kappaB_NN
-LRB-_-LRB-
NF-kappaB_NN
-RRB-_-RRB-
,_,
using_VBG
a_DT
specific_JJ
NF-kappaB_NN
oligoprobe_NN
in_IN
an_DT
electrophoretic_JJ
mobility_NN
shift_NN
assay_NN
._.

RESULTS_NNS
:_:
Six_CD
mAECA_NNS
were_VBD
selected_VBN
,_,
the_DT
mixture_NN
of_IN
which_WDT
produced_VBD
100_CD
%_NN
inhibition_NN
of_IN
binding_NN
of_IN
the_DT
original_JJ
IgG_NN
-LRB-_-LRB-
from_IN
the_DT
patient_NN
with_IN
Takayasu_NN
arteritis_NN
-RRB-_-RRB-
to_TO
HUVEC_NN
._.

All_DT
mAECA_NNS
possessed_VBD
high_JJ
activity_NN
against_IN
macrovascular_JJ
EC_NNS
,_,
but_CC
none_DT
had_VBD
significant_JJ
antimicrovascular_JJ
EC_NN
activity_NN
._.

The_DT
mAECA_NNS
,_,
but_CC
not_RB
normal_JJ
human_JJ
IgG_NN
,_,
had_VBD
anti-human_JJ
aortic_JJ
EC_NN
activity_NN
._.

Four_CD
of_IN
the_DT
6_CD
mAECA_NNS
activated_VBD
EC_NN
,_,
manifested_VBN
by_IN
increased_VBN
IL-6_NN
and_CC
vWF_NN
secretion_NN
._.

The_DT
4_CD
mAECA_NNS
induced_VBD
EC_NN
expression_NN
of_IN
adhesion_NN
molecules_NNS
and_CC
increased_VBD
adhesion_NN
of_IN
U937_NN
monocytic_JJ
cells_NNS
to_TO
EC_NN
._.

In_IN
addition_NN
,_,
these_DT
mAECA_NNS
stimulated_VBD
the_DT
nuclear_JJ
translocation_NN
of_IN
the_DT
NF-kappaB_NN
transcription_NN
factor_NN
._.

CONCLUSION_NN
:_:
Our_PRP$
findings_NNS
suggest_VBP
that_IN
AECA_NNS
may_MD
directly_RB
stimulate_VB
EC_NN
in_IN
Takayasu_NN
arteritis_NN
through_IN
elevation_NN
of_IN
adhesion_NN
molecule_NN
expression_NN
associated_VBN
with_IN
NF-kappaB_NN
activation_NN
and_CC
adhesion_NN
of_IN
monocytes_NNS
,_,
and_CC
may_MD
therefore_RB
play_VB
a_DT
pathogenic_JJ
role_NN
in_IN
the_DT
development_NN
of_IN
the_DT
vasculopathy_NN
in_IN
Takayasu_NN
arteritis_NN
._.

